Cargando…
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features
About 5–10% of breast cancers are hereditary; a genetically and clinically heterogeneous disease in which several susceptibility genes, including BRCA1, have been identified. While distinct tumour features can be used to estimate the likelihood that a breast tumour is caused by a BRCA1 germline muta...
Autores principales: | Berns, E M J J, Staveren, I L van, Verhoog, L, Ouweland, A M W van de, Gelder, M Meijer-van, Meijers-Heijboer, H, Portengen, H, Foekens, J A, Dorssers, L C J, Klijn, J G M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364107/ https://www.ncbi.nlm.nih.gov/pubmed/11506493 http://dx.doi.org/10.1054/bjoc.2001.1937 |
Ejemplares similares
-
Expression profiling of BRCA1 associated breast tumors
por: Berns, EMJJ, et al.
Publicado: (2000) -
Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000) -
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
por: Schuyer, M., et al.
Publicado: (1996) -
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000) -
Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1998)